Prognostic factors of patients with yolk sac tumors of the ovary
Authors:
- Akihiro NawaANAkihiro Nawa
- Naoko ObataNONaoko Obata
- Fumitaka KikkawaFKFumitaka Kikkawa
- Michiyasu KawaiMKMichiyasu Kawai
- Tetsuo NagasakaTNTetsuo Nagasaka
- Setsuko GotoSGSetsuko Goto
- Katsuhiko NishimoriKNKatsuhiko Nishimori
- Nobuo NakashimaNNNobuo Nakashima
- 1 May 2001
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 184 (6) , 1182-1188
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- P53 tumour suppressor gene and germ cell neoplasiaAPMIS, 1998
- Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic StrategiesJNCI: Journal of the National Cancer Institute, 1996
- Absence of Significant Germ Line p53 Mutations in Ovarian Cancer PatientsGynecologic Oncology, 1995
- Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1994
- Update on malignant ovarian germ cell tumorsCancer, 1993
- Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 casesCancer, 1991
- Study of ovarian tumors treated at Nagoya University Hospital, 1965–1988Gynecologic Oncology, 1990
- Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: An updateGynecologic Oncology, 1987
- Endodermal sinus tumor and embryonal carcinoma of the ovary in childrenGynecologic Oncology, 1985
- Endodermal sinus tumor of the ovary.A clinical and pathologic analysis of 71 casesCancer, 1976